References
Franssen B, Tabrizian P, Weinberg A, et al. Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Ann Surg Oncol. 2015;22:1639–44. https://doi.org/10.1245/s10434-014-4083-x.
Pestieau SR, Esquivel J, Sugarbaker PH. Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome. Ann Surg Oncol. 2000;7:199–203. https://doi.org/10.1007/BF02523654.
Zoetmulder FA, Sugarbaker PH. Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin. Eur J Cancer. 1996;32A:1727–33.
Nikiforchin A, Gushchin V, Sittig M, et al. Outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy with and without diaphragmatic resection in patients with peritoneal metastases. Ann Surg Oncol. 2022;29:873–82. https://doi.org/10.1245/s10434-021-10669-9.
Liu G, Ji Z, Li X, et al. Outcomes following cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy with diaphragm resection for peritoneal carcinomatosis: a retrospective cohort study. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14470-8.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare no conflicts of interest regarding the publication of this paper.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Liu, G., Li, Y. ASO Author Reflections: Which is the Better Choice for Patients with PC Who Underwent Diaphragm Resection: HIPEC or HITAC. Ann Surg Oncol 31, 1069–1070 (2024). https://doi.org/10.1245/s10434-023-14548-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14548-3